OXPRENOLOL HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for oxprenolol hydrochloride and what is the scope of patent protection?
Oxprenolol hydrochloride
is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for OXPRENOLOL HYDROCHLORIDE
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 79 |
| DailyMed Link: | OXPRENOLOL HYDROCHLORIDE at DailyMed |
Medical Subject Heading (MeSH) Categories for OXPRENOLOL HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for OXPRENOLOL HYDROCHLORIDE
US Patents and Regulatory Information for OXPRENOLOL HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | TRASICOR | oxprenolol hydrochloride | CAPSULE;ORAL | 018166-002 | Dec 28, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Novartis | TRASICOR | oxprenolol hydrochloride | CAPSULE;ORAL | 018166-004 | Dec 28, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Novartis | TRASICOR | oxprenolol hydrochloride | CAPSULE;ORAL | 018166-003 | Dec 28, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Novartis | TRASICOR | oxprenolol hydrochloride | CAPSULE;ORAL | 018166-001 | Dec 28, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OXPRENOLOL HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Novartis | TRASICOR | oxprenolol hydrochloride | CAPSULE;ORAL | 018166-002 | Dec 28, 1983 | 3,483,221 | ⤷ Start Trial |
| Novartis | TRASICOR | oxprenolol hydrochloride | CAPSULE;ORAL | 018166-004 | Dec 28, 1983 | 3,483,221 | ⤷ Start Trial |
| Novartis | TRASICOR | oxprenolol hydrochloride | CAPSULE;ORAL | 018166-003 | Dec 28, 1983 | 3,483,221 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
